(VIANEWS) – Another day of trading has ended and here’s today’s list of stocks that have had significant trading activity in the US session.

The three biggest winners today are BioCardia, Aileron Therapeutics, and Restoration Hardware Holdings.

The three biggest losers today are AGM Group Holdings, AMC, and MicroStrategy.

Winners today

1. BioCardia (BCDAW) – 28.76%

BioCardia, Inc., a clinical-stage regenerative medicine company, engages in development of cellular and cell-derived therapeutics for cardiovascular and pulmonary diseases. Its lead therapeutic candidate is the CardiAMP, an autologous mononuclear cell therapy system for the treatment of heart failure and chronic myocardial ischemia; and allogeneic cell therapy for cardiac and pulmonary disease. The company is also developing allogeneic cells therapeutic platform, an investigational culture expanded bone marrow derived mesenchymal cell therapy, which is in Phase I/II trial for the treatment of ischemic heart failure. In addition, it offers the Helix biotherapeutic delivery system that delivers therapeutics into the heart muscle with a penetrating helical needle from within the heart; and Morph deflectable guides and sheaths. The company is based in Sunnyvale, California.

NASDAQ ended the session with BioCardia jumping 28.76% to $0.02 on Thursday while NASDAQ dropped 0.12% to $16,379.46.

Earnings Per Share

As for profitability, BioCardia has a trailing twelve months EPS of $-3.2.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -703.62%.

Yearly Top and Bottom Value

BioCardia’s stock is valued at $0.02 at 17:32 EST, above its 52-week high of $0.02.

More news about BioCardia.

2. Aileron Therapeutics (ALRN) – 19.91%

Aileron Therapeutics, Inc. operates as a clinical stage chemoprotection oncology company in the United States. The company is developing ALRN-6924, which is in Phase 1 trial for solid tumor and lymphoma; Phase 2a clinical trial to treat peripheral T-cell lymphoma; Phase I clinical trial for the treatment of acute myeloid leukemia (AML) and advanced myelodysplastic syndrome (MDS); Phase 1b trial to test the combination of ALRN-6924 and cytarabine, or Ara-C, in patients with MDS; and a Phase 2a combination trial of ALRN-6924 and palbociclib in patients with tumors harboring MDM2 amplifications co-amplifications, as well as for patients with p53-mutated small cell lung cancer that has completed Phase 1b clinical trial. Aileron Therapeutics, Inc. has a license agreement with Dana-Farber Cancer Institute and Harvard College; and Umicore Precious Metals Chemistry USA, LLC. The company was formerly known as Renegade Therapeutics, Inc. and changed its name to Aileron Therapeutics, Inc. in February 2007. Aileron Therapeutics, Inc. was incorporated in 2001 and is based in Boston, Massachusetts.

NASDAQ ended the session with Aileron Therapeutics rising 19.91% to $6.93 on Thursday while NASDAQ fell 0.12% to $16,379.46.

Earnings Per Share

As for profitability, Aileron Therapeutics has a trailing twelve months EPS of $-2.85.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -76.36%.

More news about Aileron Therapeutics.

3. Restoration Hardware Holdings (RH) – 17.18%

RH, together with its subsidiaries, operates as a retailer in the home furnishings and operates under RH Galleries and RH brand names in the District of Columbia and Canada, as well as Waterworks showrooms throughout the United States and the United Kingdom. It offers products in various categories, including furniture, lighting, textiles, bathware, décor, outdoor and garden, and child and teen furnishings. The company provides its products through its retail galleries; online through rh.com, rhbabyandchild.com, rhteen.com, and rhmodern.com, as well as waterworks.com, and Source Books, a series of catalogs. The company was formerly known as Restoration Hardware Holdings, Inc. and changed its name to RH in January 2017. RH was incorporated in 2011 and is headquartered in Corte Madera, California.

NYSE ended the session with Restoration Hardware Holdings jumping 17.18% to $347.99 on Thursday while NYSE rose 0.31% to $18,312.67.

Earnings Per Share

As for profitability, Restoration Hardware Holdings has a trailing twelve months EPS of $9.47.

PE Ratio

Restoration Hardware Holdings has a trailing twelve months price to earnings ratio of 36.75. Meaning, the purchaser of the share is investing $36.75 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 46.44%.

Sales Growth

Restoration Hardware Holdings’s sales growth is 0.7% for the present quarter and 4.7% for the next.

Volume

Today’s last reported volume for Restoration Hardware Holdings is 4628490 which is 750.22% above its average volume of 544383.

More news about Restoration Hardware Holdings.

4. Matterport
(MTTR) – 15.9%

Matterport, Inc., a spatial data company, focuses on digitization and datafication in the United States and internationally. The company offers Matterport Capture Services, a fully managed solution for enterprise subscribers; Matterport Pro3, a 3D camera that scans properties; Matterport Pro2, a 3D camera that captures spaces; LEICA BLK360, a device to create digital twins; Smartphone Capture, a smartphone capture solution for both iOS and Android; and 360 Cameras. It also provides Matterport Axis, a motor-mount accessory for smartphone. The company serves its products in residential and commercial real estate, facilities management and retail, AEC, insurance and repair, and travel and hospitality markets. Matterport, Inc. is headquartered in Sunnyvale, California.

NASDAQ ended the session with Matterport
rising 15.9% to $2.26 on Thursday, after four sequential sessions in a row of gains. NASDAQ slid 0.12% to $16,379.46, following the last session’s upward trend on what was a somewhat down trend trading session today.

Earnings Per Share

As for profitability, Matterport
has a trailing twelve months EPS of $-0.66.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -35.77%.

Earnings Before Interest, Taxes, Depreciation, and Amortization

Matterport
‘s EBITDA is 1.42.

Volatility

Matterport
‘s last week, last month’s, and last quarter’s current intraday variation average was a negative 1.47%, a negative 0.93%, and a positive 3.17%.

Matterport
‘s highest amplitude of average volatility was 1.84% (last week), 2.80% (last month), and 3.17% (last quarter).

Yearly Top and Bottom Value

Matterport
‘s stock is valued at $2.26 at 17:32 EST, way below its 52-week high of $3.78 and way higher than its 52-week low of $1.84.

Growth Estimates Quarters

The company’s growth estimates for the ongoing quarter and the next is 57.1% and 57.1%, respectively.

More news about Matterport
.

5. Matterport
(MTTR) – 15.9%

Matterport, Inc., a spatial data company, focuses on digitization and datafication in the United States and internationally. The company offers Matterport Capture Services, a fully managed solution for enterprise subscribers; Matterport Pro3, a 3D camera that scans properties; Matterport Pro2, a 3D camera that captures spaces; LEICA BLK360, a device to create digital twins; Smartphone Capture, a smartphone capture solution for both iOS and Android; and 360 Cameras. It also provides Matterport Axis, a motor-mount accessory for smartphone. The company serves its products in residential and commercial real estate, facilities management and retail, AEC, insurance and repair, and travel and hospitality markets. Matterport, Inc. is headquartered in Sunnyvale, California.

NASDAQ ended the session with Matterport
rising 15.9% to $2.26 on Thursday, after four sequential sessions in a row of gains. NASDAQ slid 0.12% to $16,379.46, following the last session’s upward trend on what was a somewhat bearish trend trading session today.

Earnings Per Share

As for profitability, Matterport
has a trailing twelve months EPS of $-0.66.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -35.77%.

Volatility

Matterport
‘s last week, last month’s, and last quarter’s current intraday variation average was a negative 1.47%, a negative 0.93%, and a positive 3.17%.

Matterport
‘s highest amplitude of average volatility was 1.84% (last week), 2.80% (last month), and 3.17% (last quarter).

More news about Matterport
.

6. Golden Bull Limited (BTBT) – 14.8%

Bit Digital, Inc., together with its subsidiaries, engages in the bitcoin mining business. It is also involved in the treasury management activities; and digital asset staking and digital asset mining businesses, as well as ethereum staking activities. The company was formerly known as Golden Bull Limited and changed its name to Bit Digital, Inc. in September 2020. Bit Digital, Inc. was founded in 2015 and is headquartered in New York, New York.

NASDAQ ended the session with Golden Bull Limited jumping 14.8% to $2.87 on Thursday while NASDAQ slid 0.12% to $16,379.46.

Earnings Per Share

As for profitability, Golden Bull Limited has a trailing twelve months EPS of $-0.16.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -11.45%.

Revenue Growth

Year-on-year quarterly revenue growth grew by 106.4%, now sitting on 44.92M for the twelve trailing months.

Earnings Before Interest, Taxes, Depreciation, and Amortization

Golden Bull Limited’s EBITDA is 6.39.

Moving Average

Golden Bull Limited’s value is above its 50-day moving average of $2.62 and below its 200-day moving average of $2.91.

Yearly Top and Bottom Value

Golden Bull Limited’s stock is valued at $2.87 at 17:32 EST, way under its 52-week high of $5.27 and way above its 52-week low of $1.41.

More news about Golden Bull Limited.

7. Nikola (NKLA) – 14.4%

Nikola Corporation operates as a technology innovator and integrator that develops energy and transportation solutions in the United States and internationally. The company operates in truck and energy units. It commercializes battery electric vehicles (BEV) and hydrogen fuel cell electric vehicles (FCEV) to the trucking sector. In addition, it develops a network of hydrogen fueling stations; and offers BEV charging solutions for its FCEV and BEV customers, as well as other third-party customers. Further, its products include Nikola Tre Class 8 truck and the Nikola's Class 8 FCEV. Additionally, the company assembles, integrates, and commissions its vehicles in collaboration with its business partners and suppliers. Nikola Corporation founded in 2015 and is headquartered in Phoenix, Arizona.

NASDAQ ended the session with Nikola jumping 14.4% to $1.04 on Thursday while NASDAQ dropped 0.12% to $16,379.46.

Earnings Per Share

As for profitability, Nikola has a trailing twelve months EPS of $-1.21.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -138.82%.

Sales Growth

Nikola’s sales growth is 20.1% for the ongoing quarter and 54.9% for the next.

More news about Nikola.

8. Annexon (ANNX) – 13.52%

Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutics for autoimmune and neurodegenerative diseases. It focuses on the treatment of body, brain, and eye disorders. The company's C1q is an initiating molecule of the classical complement pathway that targets distinct disease processes, such as antibody-mediated autoimmune disease and complement-mediated neurodegeneration. Its product candidates include ANX005, which has completed Phase 1b clinical trials to treat patients with guillain- barré syndrome; and ANX007, which has completed Phase 1b clinical trials to treat patients with glaucoma. The company's candidates also comprise ANX005 that has completed preclinical trials to treat patients with warm autoimmune hemolytic anemia, Huntington's disease, and amyotrophic lateral sclerosis; ANX007, which has completed preclinical trials for the treatment of geographic atrophy; and ANX009 that has completed preclinical trials for the treatment of systemic autoimmune diseases. The company was founded in 2011 and is headquartered in South San Francisco, California.

NASDAQ ended the session with Annexon jumping 13.52% to $7.81 on Thursday, after two sequential sessions in a row of gains. NASDAQ slid 0.12% to $16,379.46, following the last session’s upward trend on what was a somewhat down trend exchanging session today.

Earnings Per Share

As for profitability, Annexon has a trailing twelve months EPS of $-1.81.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -55.73%.

Volume

Today’s last reported volume for Annexon is 5533430 which is 274.06% above its average volume of 1479290.

Earnings Before Interest, Taxes, Depreciation, and Amortization

Annexon’s EBITDA is 1.03.

More news about Annexon.

9. Alterity Therapeutics Limited (ATHE) – 11.6%

Alterity Therapeutics Limited researches and develops therapeutic drugs for the treatment of Parkinsonian's disease and other neurodegenerative diseases in Australia. The company's lead drug candidates is ATH434 that has completed Phase I clinical trial for the treatment of Parkinson's disease. It is also developing PBT2 for used as an antimicrobial agent. The company was formerly known as Prana Biotechnology Limited and changed its name to Alterity Therapeutics Limited in April 2019. The company was founded in 1997 and is based in Melbourne, Australia.

NASDAQ ended the session with Alterity Therapeutics Limited rising 11.6% to $2.02 on Thursday, after two sequential sessions in a row of gains. NASDAQ slid 0.12% to $16,379.46, following the last session’s upward trend on what was a somewhat bearish trend trading session today.

Earnings Per Share

As for profitability, Alterity Therapeutics Limited has a trailing twelve months EPS of $-1.88.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -53.72%.

Yearly Top and Bottom Value

Alterity Therapeutics Limited’s stock is valued at $2.02 at 17:32 EST, way below its 52-week high of $5.41 and way higher than its 52-week low of $1.55.

Volume

Today’s last reported volume for Alterity Therapeutics Limited is 101867 which is 144.66% above its average volume of 41636.

More news about Alterity Therapeutics Limited.

10. Altus Midstream Company (ALTM) – 10.2%

Altus Midstream Company owns gas gathering, processing, and transmission assets in the Permian Basin of West Texas. As of December 31, 2020, its assets included approximately 182 miles of in-service natural gas gathering, 46 miles of residue gas, and 38 miles of natural gas liquids (NGL) pipelines; three cryogenic processing trains; and an NGL truck loading terminal with six lease automatic custody transfer units and eight NGL bullet tanks. The company is based in Houston, Texas.

NASDAQ ended the session with Altus Midstream Company rising 10.2% to $4.43 on Thursday while NASDAQ dropped 0.12% to $16,379.46.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 17.71%.

More news about Altus Midstream Company.

Losers Today

1. AGM Group Holdings (AGMH) – -16.59%

AGM Group Holdings Inc., an integrated technology company, focuses on ASIC chip solutions. Its ASIC chip solutions include chip design, chip research and development, and crypto miner production. It also provides fintech software services. The company offers multi-assets trading and management systems to small and mid-size broker and institutional clients; and interactive trading education website that uses subscription-based method. Its FXSC is an online trading education and social trading network platform for forex traders; and provides trading education to users through interactive trading simulation and trading contests, as well as demo trading services. In addition, the company sells technical support plans; and delivers software customization services. The company was incorporated in 2015 and is based in Wan Chai, Hong Kong.

NASDAQ ended the session with AGM Group Holdings dropping 16.59% to $1.61 on Thursday, after three successive sessions in a row of losses. NASDAQ fell 0.12% to $16,379.46, following the last session’s upward trend on what was a somewhat down trend exchanging session today.

Earnings Per Share

As for profitability, AGM Group Holdings has a trailing twelve months EPS of $0.45.

PE Ratio

AGM Group Holdings has a trailing twelve months price to earnings ratio of 3.58. Meaning, the purchaser of the share is investing $3.58 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 33.17%.

Volume

Today’s last reported volume for AGM Group Holdings is 162543 which is 149.49% above its average volume of 65150.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, AGM Group Holdings’s stock is considered to be overbought (>=80).

More news about AGM Group Holdings.

2. AMC (AMC) – -14.29%

AMC Entertainment Holdings, Inc., through its subsidiaries, engages in the theatrical exhibition business. It owns, operates, or has interests in theatres in the United States and Europe. The company was founded in 1920 and is headquartered in Leawood, Kansas.

NYSE ended the session with AMC falling 14.29% to $3.72 on Thursday, following the last session’s upward trend. NYSE jumped 0.31% to $18,312.67, following the last session’s upward trend on what was a somewhat positive trend exchanging session today.

AMC entertainment stock news: AMC sheds 14% after offering to sell $250 million in common stockThe hedge fund originally faced a $20 million lawsuit from AMC shareholders for its profiting off a short-swing episode involving APE equity units., On the technical front, there is also no respite in sight for AMC other than the $3.60 support from early February.

Earnings Per Share

As for profitability, AMC has a trailing twelve months EPS of $-2.1.

Growth Estimates Quarters

The company’s growth estimates for the ongoing quarter is 52% and a drop 400% for the next.

Earnings Before Interest, Taxes, Depreciation, and Amortization

AMC’s EBITDA is 1.95.

Previous days news about AMC

• AMC networks inc. announces pricing of upsized private offering of $875 million of 10.25% senior secured notes due 2029. According to GlobeNewsWire on Tuesday, 26 March, "The Notes will be unconditionally guaranteed, on a joint and several basis, by each of AMC Networks’ existing and future domestic subsidiaries, subject to certain exceptions, on a senior secured basis.", "The company also operates AMC Studios, its in-house studio, production and distribution operation behind acclaimed and fan-favorite original franchises including The Walking Dead Universe and the Anne Rice Immortal Universe; and AMC Networks International, its international programming business."

More news about AMC.

3. MicroStrategy (MSTR) – -11.18%

MicroStrategy Incorporated provides artificial intelligence-powered enterprise analytics software and services in the United States, Europe, the Middle East, Africa, and internationally. It offers MicroStrategy ONE, which provides non-technical users with the ability to directly access novel and actionable insights for decision-making; and MicroStrategy Cloud for Government service, which offers always-on threat monitoring that meets the rigorous technical and regulatory needs of governments and financial institutions. The company also provides MicroStrategy Support that helps customers achieve their system availability and usage goals through highly responsive troubleshooting and assistance; MicroStrategy Consulting, which provides architecture and implementation services to help customers realize their desired results; and MicroStrategy Education that offers free and paid learning options. In addition, it engages in the development of bitcoin. The company offers its services through direct sales force and channel partners. It serves the U.S. government, state and local governments, and government agencies, as well as a range of industries, including retail, banking, technology, manufacturing, insurance, consulting, healthcare, telecommunications, and the public sector. The company was incorporated in 1989 and is headquartered in Tysons Corner, Virginia.

NASDAQ ended the session with MicroStrategy sliding 11.18% to $1,704.56 on Thursday while NASDAQ slid 0.12% to $16,379.46.

Earnings Per Share

As for profitability, MicroStrategy has a trailing twelve months EPS of $26.48.

PE Ratio

MicroStrategy has a trailing twelve months price to earnings ratio of 64.37. Meaning, the purchaser of the share is investing $64.37 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 48.17%.

More news about MicroStrategy.

4. Canopy Growth (CGC) – -9.63%

Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in Canada, the United States, and Germany. It operates through two segments, Global Cannabis and Other Consumer Products. The company's products include dried cannabis flower, extracts and concentrates, beverages, gummies, and vapes. It offers its products under the Tweed, 7ACRES, 7ACRES Craft Collective, DOJA, Ace Valley, Quatreau, Deep Space, First + Free, Surity Pro, Spectrum Therapeutics, Vert, Tokyo Smoke, Twd, Martha Stewart CBD, DNA Genetics, BioSteel, Storz & Bickel, This Works, HiWay, Simple Stash, Whisl, and Truverra brands. The company was formerly known as Tweed Marijuana Inc. and changed its name to Canopy Growth Corporation in September 2015. Canopy Growth Corporation was incorporated in 2009 and is headquartered in Smiths Falls, Canada.

NASDAQ ended the session with Canopy Growth falling 9.63% to $8.63 on Thursday, after four consecutive sessions in a row of gains. NASDAQ slid 0.12% to $16,379.46, following the last session’s upward trend on what was a somewhat down trend trading session today.

Earnings Per Share

As for profitability, Canopy Growth has a trailing twelve months EPS of $-15.67.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -121.56%.

More news about Canopy Growth.

5. FibroGen (FGEN) – -8.91%

FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. Its lead product candidates are Pamrevlumab, a human monoclonal antibody targeting connective tissue growth factor that is in Phase III clinical development for the treatment of locally advanced pancreatic cancer; and Roxadustat, an oral small molecule inhibitor of hypoxia-inducible factor prolyl hydroxylase activity, which has completed Phase III clinical development for the treatment of anemia in chronic kidney disease in China, Europe, Japan, and other countries, as well as in Phase III clinical development for anemia related with myelodysplastic syndromes. The company has collaboration agreements with Astellas Pharma Inc. and AstraZeneca AB. FibroGen, Inc. was incorporated in 1993 and is headquartered in San Francisco, California.

NASDAQ ended the session with FibroGen dropping 8.91% to $2.35 on Thursday while NASDAQ slid 0.12% to $16,379.46.

Earnings Per Share

As for profitability, FibroGen has a trailing twelve months EPS of $-2.92.

Yearly Top and Bottom Value

FibroGen’s stock is valued at $2.35 at 17:32 EST, way under its 52-week high of $20.90 and way above its 52-week low of $0.33.

Sales Growth

FibroGen’s sales growth for the current quarter is 14.5%.

More news about FibroGen.

6. SNDL Inc. (SNDL) – -8.03%

SNDL Inc. engages in the production, distribution, and sale of cannabis products in Canada. The company operates through Liquor Retail, Cannabis Retail, Cannabis Operations, and Investments segments. It engages in the cultivation, distribution, and sale of cannabis for the adult-use and medical markets; sells wines, beers, and spirits through wholly owned liquor stores; and private sale of recreational cannabis through wholly owned and franchised retail cannabis stores. In addition, the company produces and distributes inhalable products, such as flower, pre-rolls, and vapes. It offers its products under the Top Leaf, Sundial Cannabis, Palmetto, and Grasslands brands. The company was formerly known as Sundial Growers Inc. and changed its name to SNDL Inc. in July 2022. SNDL Inc. was incorporated in 2006 and is headquartered in Calgary, Canada.

NASDAQ ended the session with SNDL Inc. sliding 8.03% to $2.01 on Thursday, after two consecutive sessions in a row of gains. NASDAQ dropped 0.12% to $16,379.46, following the last session’s upward trend on what was a somewhat negative trend exchanging session today.

Earnings Per Share

As for profitability, SNDL Inc. has a trailing twelve months EPS of $-0.48.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -17.6%.

Volatility

SNDL Inc.’s last week, last month’s, and last quarter’s current intraday variation average was 11.41%, 2.41%, and 3.47%.

SNDL Inc.’s highest amplitude of average volatility was 12.19% (last week), 4.60% (last month), and 3.47% (last quarter).

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, SNDL Inc.’s stock is considered to be oversold (<=20).

Earnings Before Interest, Taxes, Depreciation, and Amortization

SNDL Inc.’s EBITDA is -130.36.

More news about SNDL Inc..

7. Aurora Cannabis (ACB) – -7.58%

Aurora Cannabis Inc., together with its subsidiaries, produces, distributes, and sells cannabis and cannabis-derivative products in Canada and internationally. It operates through three segments: Canadian Cannabis, European Cannabis, and Plant Propagation. The company produces, distributes, and sells medical and consumer cannabis products in Canada. It is also involved in the distribution of wholesale medical cannabis in the European Union (EU); distribution of wholesale medical cannabis in various international markets, including Australia, the Caribbean, South America, and Israel; supply of propagated vegetables and ornamental plants in North America; and distribution and sale of hemp-derived cannabidiol (CBD) products. In addition, the company cultivates and sells dried cannabis, cannabis oils, capsules, edible cannabis, cannabis extracts, and soft gels, which are ingested in various ways, including smoking, vaporizing, and consumption in the form of oil, capsules, edibles, and extracts; and provides dried flowers, vapes, dried milled strains, strain-specific extracts, strain specific cannabis oils, and concentrates. Further, it offers recreational cannabis products, such as flowers, vapes, ingestibles, concentrates, extracts, and CBD products; and patient counseling and outreach services. The company's adult-use brand portfolio includes Aurora Drift, San Rafael '71, Daily Special, Whistler, Being, and Greybeard, as well as CBD brands, Reliva and KG7; and medical cannabis brands include MedReleaf, CanniMed, Aurora, Whistler Medical Marijuana Co, Pedanios, Bidiol, and CraftPlant. Aurora Cannabis Inc. is headquartered in Edmonton, Canada.

NYSE ended the session with Aurora Cannabis falling 7.58% to $4.39 on Thursday while NYSE jumped 0.31% to $18,312.67.

Earnings Per Share

As for profitability, Aurora Cannabis has a trailing twelve months EPS of $-58.28.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -102.67%.

Earnings Before Interest, Taxes, Depreciation, and Amortization

Aurora Cannabis’s EBITDA is 18.09.

Sales Growth

Aurora Cannabis’s sales growth for the next quarter is 7%.

More news about Aurora Cannabis.

8. ATIF Holdings Limited (ATIF) – -7.41%

ATIF Holdings Limited, a consulting company, provides financial consulting services to small and medium-sized enterprises in Asia. It primarily helps clients going public on the OTC markets and exchanges in the United States. The company was incorporated in 2015 and is headquartered in Rancho Cucamonga, California.

NASDAQ ended the session with ATIF Holdings Limited dropping 7.41% to $1.00 on Thursday while NASDAQ slid 0.12% to $16,379.46.

Earnings Per Share

As for profitability, ATIF Holdings Limited has a trailing twelve months EPS of $-0.48.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -164.01%.

Yearly Top and Bottom Value

ATIF Holdings Limited’s stock is valued at $1.00 at 17:32 EST, way under its 52-week high of $2.15 and way above its 52-week low of $0.65.

Volume

Today’s last reported volume for ATIF Holdings Limited is 2594 which is 86.01% below its average volume of 18545.

Earnings Before Interest, Taxes, Depreciation, and Amortization

ATIF Holdings Limited’s EBITDA is 24.39.

More news about ATIF Holdings Limited.

9. Senmiao Technology Limited (AIHS) – -6.58%

Senmiao Technology Limited engages in the automobile transaction and related services business in the People's Republic of China. Its services include the facilitation of automobile transaction and financing, connecting ride-hailing drivers to financial institutions to buy, or get financing on the purchase of, cars to be used to provide ride-hailing services. The company is also involved in the sale of automobiles; and provision of auto finance services. Senmiao Technology has strategic cooperation with Gaode Map for utilization in ride sharing initiatives. Senmiao Technology Limited was incorporated in 2017 and is based in Chengdu, the People's Republic of China.

NASDAQ ended the session with Senmiao Technology Limited falling 6.58% to $0.87 on Thursday, after two consecutive sessions in a row of losses. NASDAQ dropped 0.12% to $16,379.46, following the last session’s upward trend on what was a somewhat bearish trend exchanging session today.

Earnings Per Share

As for profitability, Senmiao Technology Limited has a trailing twelve months EPS of $-0.45.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -53.58%.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Senmiao Technology Limited’s stock is considered to be overbought (>=80).

Earnings Before Interest, Taxes, Depreciation, and Amortization

Senmiao Technology Limited’s EBITDA is 1.26.

Volume

Today’s last reported volume for Senmiao Technology Limited is 45955 which is 21.59% above its average volume of 37795.

More news about Senmiao Technology Limited.

10. Palantir (PLTR) – -6.12%

Palantir Technologies Inc. builds and deploys software platforms for the intelligence community to assist in counterterrorism investigations and operations in the United States, the United Kingdom, and internationally. The company provides Palantir Gotham, a software platform which enables users to identify patterns hidden deep within datasets, ranging from signals intelligence sources to reports from confidential informants, as well as facilitates the handoff between analysts and operational users, helping operators plan and execute real-world responses to threats that have been identified within the platform. It also offers Palantir Foundry, a platform that transforms the ways organizations operate by creating a central operating system for their data; and allows individual users to integrate and analyze the data they need in one place. In addition, it provides Palantir Apollo, a software that delivers software and updates across the business, as well as enables customers to deploy their software virtually in any environment; and Palantir Artificial Intelligence Platform (AIP) that provides unified access to open-source, self-hosted, and commercial large language models (LLM) that can transform structured and unstructured data into LLM-understandable objects and can turn organizations' actions and processes into tools for humans and LLM-driven agents. The company was incorporated in 2003 and is headquartered in Denver, Colorado.

NYSE ended the session with Palantir falling 6.12% to $23.01 on Thursday while NYSE rose 0.31% to $18,312.67.

Earnings Per Share

As for profitability, Palantir has a trailing twelve months EPS of $0.09.

PE Ratio

Palantir has a trailing twelve months price to earnings ratio of 255.67. Meaning, the purchaser of the share is investing $255.67 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 5.44%.

Revenue Growth

Year-on-year quarterly revenue growth grew by 16.8%, now sitting on 2.13B for the twelve trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Palantir’s stock is considered to be oversold (<=20).

Yearly Top and Bottom Value

Palantir’s stock is valued at $23.01 at 17:32 EST, above its 52-week high of $21.85.

Moving Average

Palantir’s worth is way higher than its 50-day moving average of $18.09 and way above its 200-day moving average of $15.18.

More news about Palantir.

Stay up to date with our winners and losers daily report